Updates in Myelodysplastic Syndrome

EP. 1: Diagnosis of Myelodysplastic Syndrome

January 30th 2020

EP. 2: Clinical Presentation and Symptoms of MDS

January 30th 2020

EP. 3: Risk Stratification in MDS

January 30th 2020

EP. 4: The Use of Molecular Testing in MDS

January 30th 2020

EP. 5: Factoring in Comorbidities in MDS Risk Stratification

January 30th 2020

EP. 6: Re-Staging Patients with MDS

January 30th 2020

EP. 7: Thresholds for Blood Transfusions for MDS

January 30th 2020

EP. 8: Iron Chelation Therapy for MDS

January 30th 2020

EP. 9: MDS: Low-Risk Disease Treatment Options

January 30th 2020

EP. 10: Erythropoiesis-Stimulating Agents for Lower-Risk MDS

January 30th 2020

EP. 11: Lenalidomide in Del 5q MDS

January 30th 2020

EP. 12: Phase III MEDALIST Trial of Luspatercept for MDS

January 30th 2020

EP. 13: Emerging Agents in Development for MDS

January 30th 2020

EP. 14: Final Thoughts From ASH 2019 on MDS

January 30th 2020

x